Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation.
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Embo Molecular Medicine
Her, Zhisheng Z; Teng, Terk-Shin TS; Tan, Jeslin J L JJ; Teo, Teck-Hui TH; Kam, Yiu-Wing YW; Lum, Fok-Moon FM; Lee, Wendy W L WW; Gabriel, Christelle C; Melchiotti, Rossella R; Andiappan, Anand K AK; Lulla, Valeria V; Lulla, Aleksei A; Win, Mar K MK; Chow, Angela A; Biswas, Subhra K SK; Leo, Yee-Sin YS; Lecuit, Marc M; Merits, Andres A; Rénia, Laurent L; Ng, Lisa F P LF
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.
Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology
Park, Jong Y JY; Amankwah, Ernest K EK; Anic, Gabriella M GM; Lin, Hui-Yi HY; Walls, Brooke B; Park, Hyun H; Krebs, Kevin K; Madden, Melissa M; Maddox, Kristen K; Marzban, Suroosh S; Fang, Shenying S; Chen, Wei W; Lee, Jeffrey E JE; Wei, Qingyi Q; Amos, Christopher I CI; Messina, Jane L JL; Sondak, Vernon K VK; Sellers, Thomas A TA; Egan, Kathleen M KM
Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival.
Plos One
Gast, Andreas A; Bermejo, Justo Lorenzo JL; Claus, Rainer R; Brandt, Andreas A; Weires, Marianne M; Weber, Alexander A; Plass, Christoph C; Sucker, Antje A; Hemminki, Kari K; Schadendorf, Dirk D; Kumar, Rajiv R